The Supreme Court closed the IMA’s case against Patanjali over misleading ads and lifted its stay on the Centre’s deletion of Rule 170. AYUSH medicine ads can now run without prior State licensing approval.
![[BREAKING] Patanjali Case | "Publicise complaints against misleading ads of medicines": Supreme Court Urges Centre](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/07/image-113.png?resize=447%2C367&ssl=1)
The Supreme Court Today (July 30th) suggested that the AYUSH Ministry should create a centralised dashboard to publicise and track the progress of complaints filed against misleading advertisements on medicinal or allied healthcare products. The Court was hearing a case filed against Patanjali Ayurved and its promoters, Baba Ramdev and Acharya Balkrishna for publishing misleading ads targeting allopathic medicine.
